Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

SCHWARZ PHARMA Deutschland GmbH

SCHWARZ PHARMA AG is a publicly traded company, which develops and markets innovative drugs with the focus on Central Nervous System (CNS) as well as cardiovascular and gastro-intestinal diseases employs around 4,400 professionals worldwide operates state of the art manufacturing facilities in Europe,USA and Asia has a strong multinational marketing presence and infrastructur with affiliates in the USA, Europe and Asia is headquartered in Monheim, Germany.


Contact Details:
Alfred-Nobel-Str. 10
Monheim
40789
Germany
Tel:49 2173 48 4848
Fax:49 2173 48 4841
Email:service@schwarzpharma.com
WWW:

www.schwarzpharma.de/




Recent Publications by SCHWARZ PHARMA Deutschland GmbH:

Treatment costs and quality of life of patients with peripheral arterial occlusive disease--the German perspective.
BACKGROUND: To objectify the debate about the restricted resources of the...
16th December, 2004
Schwarz Pharma Deutschland GmbH, Monheim, Germany. Vasa. 2004 Aug;33(3):145-53.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 78 times since April 2007, the link to the organisation's website has been followed 17 times

Search for more companies in Monheim

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SCHWARZ PHARMA Deutschland GmbH

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.